## Abstract At present, the pharmacotherapy of Parkinson's disease (PD) consists mainly of Lβdihydroxyphenylalanine (LβDOPA) and/or dopamine D~2~ receptor agonist. However, in general the clinical efficacy of D~2~ agonists is less than that of LβDOPA. Therefore, attention is being focussed on the r
β¦ LIBER β¦
Reinforcing effect of the D1dopamine agonist SKF 81297 in rhesus monkeys
β Scribed by Michael R. Weed; Kimberly E. Vanover; William L. Woolverton
- Publisher
- Springer
- Year
- 1993
- Tongue
- English
- Weight
- 281 KB
- Volume
- 113
- Category
- Article
- ISSN
- 0033-3158
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
The dopamine D1 agonist SKF 81297 and th
β
R. J. Vermeulen; Dr. B. Drukarch; M. C. R. Sahadat; C. Goosen; E. C. Wolters; J.
π
Article
π
1994
π
John Wiley and Sons
π
English
β 902 KB
Effects of chronic administration of the
β
Nicole H. Mutschler; Jack Bergman
π
Article
π
2002
π
Springer
π
English
β 128 KB
Selective effects of the D1dopamine rece
β
Jonathan L. Katz; Jeffrey M. Witkin
π
Article
π
1992
π
Springer
π
English
β 476 KB
Evidence for postsynaptic dopamine agoni
β
Leonard T. Meltzer; James N. Wiley; Ann E. Williams; Thomas G. Heffner
π
Article
π
1988
π
Springer
π
English
β 403 KB
Effect of cocaine self-administration on
β
Rodney J. Moore; Sharon L. Vinsant; Michael A. Nader; Linda J. Porrino; David P.
π
Article
π
1998
π
John Wiley and Sons
π
English
β 382 KB
π 2 views
An array of evidence indicates that long-term exposure to cocaine alters several components of the brain dopamine system. Because the release of dopamine in the nucleus accumbens (NAc) has been implicated in mediating the reinforcing effects of cocaine, changes in dopamine function can have profound
Sub-chronic administration of the dopami
β
G. Andringa; J. C. Stoof; A. R. Cools
π
Article
π
1999
π
Springer
π
English
β 81 KB